FPH1 (BRD-6125) Hepatocyte Expansion Guide
2026-08-14
FPH1 (BRD-6125) supports functional expansion workflows that measure more than cell number, linking hepatocyte proliferation with albumin, CYP3A4, and AFP readouts. This guide covers primary human hepatocyte culture, iPSC-derived hepatocyte assays, compound handling, and practical troubleshooting.
Cepharanthine and Endometriosis: Organoid Evidence
2026-08-13
The 2026 reference study evaluates Cepharanthine across endometriotic stromal cells, patient-derived endometrial organoids, and a murine peritoneal model. Its central contribution is a translational evidence chain linking reduced proliferation to DNA damage, impaired repair, cell-cycle arrest, and mitochondrial apoptosis, while also defining the limits of preclinical interpretation.
SU5416: VEGFR2 Workflows for Angiogenesis
2026-08-13
SU5416 (Semaxanib) provides a practical VEGFR2-focused tool for separating VEGF-driven endothelial responses from broader effects on proliferation and survival. This guide connects angiogenesis assays with the AURKB-centered pulmonary hypertension study while emphasizing dose design, controls, formulation, and interpretation limits.
Bestatin as a Chemical Probe of Jasmonate Signaling
2026-08-12
The reference study established bestatin as a selective chemical perturbation of jasmonate-associated responses in Arabidopsis and tomato, while showing that its activity depends on COI1 but not strictly on jasmonate biosynthesis. By combining transcriptomics, developmental phenotyping, and bestatin-resistant mutants, the authors developed a chemical-genetic framework for identifying previously unrecognized regulators of jasmonate signaling.
BKT140 (BL-8040) CXCR4 Research Workflows
2026-08-12
BKT140, also called BL-8040 and TF 14016, supports practical studies of CXCR4-driven migration, tumor–microenvironment signaling, apoptosis, and stem cell mobilization. This guide translates receptor biology and recent theranostic insights into assay-ready workflows, formulation guidance, and troubleshooting strategies.
BCECF Workflows for Extracellular pH Research
2026-08-11
BCECF converts extracellular acid-base changes into a quantitative ratiometric readout for ion transport, metabolism, and immune-microenvironment studies. This workflow shows how to apply the probe to neuropathic pain research while separating validated pathway evidence from testable pH hypotheses.
Firefly Luciferase mRNA as an Assay Calibrator
2026-08-10
Firefly Luciferase mRNA (ARCA, 5-moUTP) is more than a luminescent reporter: it can help separate transcript delivery, translation, and assay chemistry. This article connects its molecular design to delivery-platform evidence and more defensible gene expression, viability, and imaging decisions.
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-08-09
This review frames tumor hypoxia and immunometabolism as a reinforcing feedback system rather than as separate features of cancer biology. Its main practical contribution is a mechanistic map linking oxygen limitation, nutrient competition, immune-cell dysfunction, and therapeutic resistance, while highlighting experimental strategies for connecting metabolic and redox measurements to tumor–immune interactions.
Galectin-1, FIP200, and Hepatic Steatosis
2026-08-08
The reference study identifies a Galectin-1–FIP200 interaction as an upstream mechanism that suppresses autophagy and promotes hepatic steatosis, dyslipidemia, and insulin resistance. Its combination of mouse models, proteomic analysis, interaction mapping, and mutational validation provides a mechanistic framework for studying autophagy failure in NAFLD.
Reactive Oxygen Species Assay Kit for Radiotherapy
2026-08-07
A translational perspective on using DCFH-DA-based ROS measurement to connect FLASH-RT radiosensitization, oxidative damage, apoptosis, and immune remodeling with decision-grade experimental workflows.
Tacalcitol Monohydrate Enhances 5-FU Sensitivity in CRC Cell
2026-08-07
This article reviews a study demonstrating that tacalcitol, a synthetic analog of vitamin D3, significantly increases the sensitivity of colorectal cancer (CRC) cells to 5-fluorouracil (5-FU) by downregulating thymidylate synthase via vitamin D receptor (VDR)-dependent pathways. The findings provide mechanistic insight into how vitamin D analogs can be leveraged to improve standard chemotherapy outcomes in CRC models.
Tropisetron Hydrochloride: Beyond 5-HT3 Antagonism in Resear
2026-08-06
Explore Tropisetron Hydrochloride as a leading 5-HT3 receptor antagonist for advanced serotonin receptor signaling research. This article reveals new mechanistic insights from transporter inhibition studies, bridging molecular pharmacology with practical assay design.
Synergistic Colistin–Gamithromycin Action Against P. multoci
2026-08-06
This study demonstrates that combining colistin with gamithromycin significantly enhances antimicrobial activity against Pasteurella multocida in a neutropenic murine lung infection model. The findings reveal potent synergy, particularly for high-colistin MIC isolates, and offer insights into optimizing therapeutic regimens to combat resistance in veterinary pathogens.
Murine RNase Inhibitor (K1046): Reliable RNA Protection in A
2026-08-05
This article details real laboratory challenges in RNA-based assays, demonstrating how Murine RNase Inhibitor (SKU K1046) delivers robust RNA degradation prevention and workflow reproducibility. Scenario-based Q&A provides actionable insight for biomedical researchers, with cited data and practical protocols to ensure assay sensitivity and reliability.
SB 431542: Selective ALK5 Inhibitor for TGF-β Pathway Studie
2026-08-05
SB 431542 is a potent, selective ALK5 inhibitor widely used to dissect TGF-β signaling in cellular and animal models. It blocks Smad2 phosphorylation, impacts cell proliferation, and demonstrates immunomodulatory effects, with robust selectivity and solubility features for research applications.
466 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page